SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy
Research Paper
[키워드] acute respiratory syndrome
Antibody test
appear
Applying
Biomathematics
biostatistics
Cohort
complement
conducted
core
coronavirus
Corporation
Critical
diagnosed
Efficacy
elicit
epidemiological
Epidemiology
Evidence
finding
Follow-up
funding
genetics
Genome sequencing
Genomics
Immunity
incidence
incidence rate
individual
individuals
Infection
infections
International
investigated
less
median
moderate
MOST
natural
natural infection
PCR positive
PCR-positive
Program
PROTECT
Public
public health
raising
random
Reinfection
SARS-CoV-2
Seven
specimen
Swab
through contact
Viral genome sequencing
were assessed
[DOI] 10.1016/j.eclinm.2021.100861 PMC 바로가기 [Article Type] Research Paper
[DOI] 10.1016/j.eclinm.2021.100861 PMC 바로가기 [Article Type] Research Paper